Association between serum α-klotho level and the prevalence of heart failure in the general population

Weimin Luo1, Na Wei1, Zhaoling Sun1

  • 1Department of Cardiology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Cardiac Electrophysiology and Arrhythmia, Jinan, Shandong, China.

PubMed

Insights

Higher serum alpha-klotho levels are linked to a lower prevalence of heart failure in American adults. This association varied significantly based on gender and race, indicating potential differences in cardiovascular health.

Area of Science:

  • Cardiovascular Research
  • Endocrinology
  • Gerontology

Background:

  • Heart failure presents a significant global health challenge, impacting morbidity and mortality worldwide.
  • While animal studies suggest cardioprotective effects of alpha-klotho, its role in human cardiovascular disease remains debated.
  • This study investigates the relationship between serum alpha-klotho levels and heart failure prevalence in the US general population.

Purpose of the Study:

  • To examine the association between serum alpha-klotho levels and the prevalence of heart failure.
  • To explore potential variations in this association based on demographic factors like gender and race.

Main Methods:

  • Utilized data from 11,271 participants (aged 40-80) in the National Health and Nutrition Examination Survey (NHANES).
  • Measured serum alpha-klotho levels via ELISA and categorized them into quartiles.
  • Employed multivariate logistic regression, interaction, and stratified analyses to assess the association and potential modifiers.

Main Results:

  • An inverse association was observed between serum alpha-klotho levels and heart failure prevalence, even after adjusting for covariates (OR: 0.76 per SD increase).
  • Participants in higher quartiles of alpha-klotho showed reduced odds of heart failure compared to the lowest quartile.
  • Stratified analyses indicated significant differences in the association based on gender and race.

Conclusions:

  • Serum alpha-klotho level is independently associated with heart failure prevalence in the American general population.
  • The observed association between alpha-klotho and heart failure is not uniform and is influenced by gender and race.
  • Further research is warranted to elucidate the mechanisms underlying these demographic variations.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
20
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
14
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
18